Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT02370797

Node Negative, Invasive Breast Cancer Single Fraction IOERT

Lumpectomy Followed by Intraoperative Electron Radiation Therapy (IOERT) as a Single Full Dose Partial Breast Irradiation for Early Stage, Node Negative, Invasive Breast Cancer

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Avera McKennan Hospital & University Health Center · Academic / Other
Sex
Female
Age
60 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine if lumpectomy followed by Intraoperative Electron Radiation Therapy (IOeRT) as a single, full dose partial breast irradiation will have as good or better results in preventing recurrence of local breast cancer, cosmetic appearance and early and late side effects.

Detailed description

See points VIII inclusion/exclusion criteria Operation: * Lumpectomy, steninal node biopsy * IOeRT After Surgery: * Meet with a medical oncologist and discuss if chemotherapy and/or hormone therapy is recommended as part of your treatment course. In some cases, pathology results may indicate the need for removal of additional lymph nodes. The doctor will review pathology and discuss if additional surgery is required. * Chemotherapy (if indicated) * Hormone therapy (if indicated) Follow-Up * Visits will be completed with the surgeon, radiation oncologist and research staff as the protocol indicates. * Assessements of acute toxicity according to CTC-toxicity scoring system * Assessments of late toxicity according to LENT-SOMA scoring systems * Assessment of cosmetic outcome according to scoring system and photo documentation in standardized positions.

Conditions

Interventions

TypeNameDescription
RADIATIONSingle Fraction IOeRTA single dose of 21 Gy calculated such that the 90% isodose line encompasses the posterior of the tumor bed will be administered.

Timeline

Start date
2015-02-01
Primary completion
2029-02-01
Completion
2029-05-01
First posted
2015-02-25
Last updated
2025-01-28

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02370797. Inclusion in this directory is not an endorsement.